Pharmaceutical composition taking cefixime and erdosteine as active component as well as preparation method and usage thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cefixime and active ingredients, which is applied in the field of medicine, and can solve the problems of compound cefixime and erdosteine related literature and patent reports, etc.
Inactive Publication Date: 2008-05-21
BEIJING RUNDEKANG MEDICAL TECH CO LTD
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] Through the search, there are no related literature
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] Example 1 Cefixime and Erdosteine Tablets
[0015] prescription:
[0016]
[0017] Preparation:
[0018] Pass erdosteine and microcrystalline cellulose through 80-mesh sieve respectively, mix evenly, add 50% ethanol solution to the mixed powder, make soft material, granulate with 24-mesh sieve, dry, granulate with 20-mesh sieve, add micropowder silica gel , CMS-Na, after mixing evenly, use a suitable die to compress the tablet, that is to say.
[0019] If the above-mentioned tablet is coated, a coated tablet can be obtained, which can be a film-coated tablet, an enteric-coated tablet, and the like.
Embodiment 2
[0020] Embodiment 2: Cefixime and Erdosteine Capsules
[0021] prescription:
[0022]
[0023] Preparation:
[0024] Pass erdosteine and cefixime through an 80-mesh sieve, and after mixing evenly, add magnesium stearate, mix evenly, and pack separately to obtain the product.
[0025] The used capsule shell can be a common capsule or an enteric-coated capsule.
Embodiment 3
[0026] Example 3: Cefixime and Erdosteine Chewable Tablets
[0027] prescription:
[0028]
[0029] Preparation:
[0030] Pass erdosteine, cefixime, xylitol, mannitol and other raw and auxiliary materials through a 80-mesh sieve respectively, and mix them uniformly by using an equal-volume increasing method. granules, dried, sieved through a 20-mesh sieve, added other flavoring agents, sweeteners, and glidants, mixed evenly, and compressed into tablets.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a pharmaceutical composition which takes cefixime and erdosteine as active ingredients, the preparation method and the usage. The invention takes cefixime and erdosteine as the pharmaceutical active ingredients, pharmaceutically acceptable excipients are mixed to form the pharmaceutical composition, and the invention can be used for the treatment of chronic bronchitis with cough, sputum and other clinical symptoms. The contents of the invention take cefixime and erdosteine as raw materials, certain specific type and proportion of excipients are added, the invention is prepared and developed into tablets, capsules, granules, dispersion tablets, chew tablets, buccal tablets, effervescent tablets, effervescent granules and other various oral preparations according to the technical means which is illustrated by the invention.
Description
technical field [0001] The invention relates to a pharmaceutical composition with cefixime and erdosteine as active components, a preparation method and application thereof, and belongs to the technical field of medicine. Background technique [0002] The antibacterial mechanism of cefixime is similar to that of other third-generation cephalosporins. By binding to one or more penicillin-binding proteins (PBPs), it inhibits the cell wall synthesis of bacterial dividing cells and makes bacteria form defective cell walls that are unstable to osmotic pressure. , thereby playing an antibacterial effect. Its antibacterial spectrum includes Streptococcus, Streptococcus pneumoniae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella, Brahamella catarrhalis, Serratia, Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Haemophilus influenzae Bacillus, etc., can be used for respiratory infections caused by sensitive bacteria, such as pneumonia, bronchitis, etc. [0003] Erd...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more